Israeli Healthcare Data Startup MDClone has raised $15 million from OrbiMed Israel Partners, who led the initial investment in 2016, and Lightspeed Venture Partners, who led the 2017 financing.
MDClone is a approaching the healthcare industry with a new way, focussing on research, analytics, privacy, and data access. The startup addresses the complications related to a vast and ever-expanding amount of data in healthcare. Current limited ability to derive comprehensive insights from available data is leading to the loss of numerous opportunities. MDClone’s Platform dramatically enhances the utility of the data and its Synthetic Data Engine offers the first solution on the market to eliminate the risk of releasing identifiable patient information when conducting healthcare analysis and research.
One of the most Passionate startup in Healthcare
Anat Naschitz, Managing Director at OrbiMed shared that Healthcare Data Startup MDClone has one of the most passionate, experienced, and innovative teams in digital health in Israel. “I believe this team can realize the significant potential afforded by the company’s unique technology, translating it into commercial success. We see the entire healthcare industry benefiting from MDClone’s solution,” he added.
MDClone is based in Beer Sheba, Israel where it was founded in 2016 by CEO Ziv Ofek (founder and former Chief Innovation Officer of dbMotion, acquired by Allscripts in 2013), CTO Luz Erez and CFO Boaz Gur-Lavie. The company released its first product in February 2017, and counts most of Israel’s healthcare system as customers. In January 2018, the company signed its first major deal in the U.S. with Washington University School of Medicine in St. Louis. The funding will be used for ongoing development of the MDClone Platform and for global expansion.